CD5 and carcinoma: Regarding immunohistochemistry, most ITTC cases were positive for CD5, a marker for carcinoma of thymic origin, as well as for p63, CD117, CK5/6 and negative for thyroid transcription factor 1 (TTF-1), to distinguish it from other thyroid tumors, also described in the literature (20).